Patent 7371376 was granted and assigned to Genentech on May, 2008 by the United States Patent and Trademark Office.
Anti-ErbB2 antibodies are described which bind to an epitope in Domain 1 of ErbB2 and induce cell death via apoptosis. Various uses for these antibodies are also described.